October 26, 2026 Personalized Cancer Vaccines Deliver: Phase 3 Trial Cuts Recurrence Risk by 42% BiomedicinemRNACancer VaccineMelanoma
October 20, 2026 Catching 87% of Animal-Missed Toxins: Why Phasing Out Lab Rabbits Takes 30 Years BiomedicineOrgan-on-a-ChipAnimal TestingClinical Trials
September 25, 2026 The Regeneration Dilemma: How the Liver Trades Cancer Risk for Infinite Regrowth BiomedicineSystems ArchitectureCancer
